How to Test Your Home for Radon
Getting your home tested for radon can help protect you and your family from a key cause of lung cancer.
Who Should Be Screened for Lung Cancer?
A harsh truth about lung cancer is that it doesn’t usually cause symptoms until the cancer is already advanced and not able to be cured. That’s why the idea of screening – looking for lung cancer in people who do not have any symptoms – is appealing.
Why Non-smokers Sometimes Get Lung Cancer
As many as 20% of the people who die from lung cancer in the United States every year do not smoke or use any other form of tobacco.
4 Cancer Screening Tests for Men
Celebrate the fathers in your life this June by encouraging them to protect their health by getting up to date on cancer screening tests.
Cancer Screening Tests All Women Should Know About
Along with giving Mother's Day gifts and sending greetings this year, encourage the moms in your life to get up to date on cancer screening tests.
FDA OKs Xalkori (Crizotinib) for Rare Type of Advanced Lung Cancer
The US Food and Drug Administration (FDA) has approved the first treatment for people with advanced, ROS1-positive non-small cell lung cancer.
Annual Report to the Nation: Cancer Death Rates Still Dropping
The death rate from cancer in the United States is continuing the decline that began in the early 1990s, according to the latest Annual Report to the Nation on the Status of Cancer.
FDA Approves Alecensa (Alectinib) for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved Alecensa (alectinib) to treat people with advanced ALK-positive non-small cell lung cancer (NSCLC) that has become worse after treatment with another targeted therapy drug called Xalkori (crizotinib). Read more here.
FDA Approves Tagrisso (Osimertinib) for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved Tagrisso (osimertinib) to treat people with a type of advanced non-small cell lung cancer.
FDA Approves Keytruda (Pembrolizumab) for Lung Cancer
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Keytruda (pembrolizumab) to treat people with advanced non-small cell lung cancer that is getting worse, even after treatment with other drugs, and whose tumors have a protein called PD-L1.
FDA Approves New Use of Iressa (Gefitinib) for EGFR-mutated Lung Cancer
Study: Smoking Causes Almost Half of Deaths from 12 Cancer Types
Almost half the deaths (48.5%) from 12 different types of cancer combined are attributable to cigarette smoking, according to a study by researchers from the American Cancer Society and colleagues.
Experimental Drugs Show Promise Against EGFR-mutated Lung Cancers
Researchers are making progress against advanced non-small cell lung cancers that have mutations in the EGFR gene.
FDA Approves Opdivo (Nivolumab) for Lung Cancer
The US Food and Drug Administration (FDA) has approved Opdivo (nivolumab) to treat people with a type of advanced lung cancer: squamous non-small cell lung cancer that has grown after they received platinum-based chemotherapy.
FDA Approves Cyramza (Ramucirumab) for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) approved Cyramza (ramucirumab) to treat people with non-small cell lung cancer that has spread beyond the lungs (metastasized), and whose tumor grew during or after treatment with certain types of chemotherapy.
Researchers Focus on Lung Cancer Treatment
Finding better ways to treat lung cancer is a priority for researchers in medical centers around the world.
Study: Chest Radiation Helps Small Cell Lung Cancer Patients Live Longer
Dutch and British researchers have found that adding chest radiation to standard treatment helped people with advanced small cell lung cancer live longer and reduced the chances of the cancer coming back in the chest.
Lung-MAP Study Pioneers New Approach to Testing Cancer Treatments
A new kind of large research study is being planned to test 5 different experimental drugs at the same time, all for advanced squamous cell lung cancer.
FDA Approves Zykadia (Ceritinib) for Advanced Lung Cancer
The US Food and Drug Administration (FDA) has approved Zykadia (ceritinib) for a type of late-stage non-small cell lung cancer.
Antioxidant Supplements Fuel Lung Cancer in Mice
Swedish researchers have found that giving antioxidant supplements to mice with small lung tumors caused the tumors to grow more quickly, become more invasive, and kill the mice faster.
Surgeon General’s Report on Smoking and Health: 50 Years of Progress
Today it’s an accepted truth that smoking causes lung cancer and other diseases, but this wasn’t always the case.
Rates Drop for New Lung Cancer Cases in the US
Anti-tobacco efforts have led to a decrease in the rate of new lung cancer cases, according to the Centers for Disease Control and Prevention (CDC).
Researchers Closing in on the Future of Lung Cancer Drugs
Researchers in medical centers around the world are learning more about lung cancer and developing new types of drugs to treat it.
US Task Force Makes Recommendations for Lung Cancer Screening
The United States Preventive Services Task Force (USPSTF) has issued a draft statement recommending that certain people at high risk for lung cancer get a low-dose CT scan every year. The task force is an independent panel of experts authorized by Congress to make recommendations about specific preventive services for patients with no signs or symptoms of disease.
FDA Approves Gilotrif (afatinib) for Non-small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved a new drug to treat non-small cell lung cancer that has spread (metastasized).
Study: Lung Screening Could Prevent 12,000 Deaths
Researchers from the American Cancer Society have found that screening former and current smokers who fall within guideline recommendations could prevent 12,000 lung cancer deaths a year in the US.
Risk of Lung Cancer Death Increased During Last 50 Years for Women Smokers
Researchers have found that changes in women’s smoking habits during the last decades have increased their risk of dying from lung cancer and COPD when compared to past female smokers.
Lung Cancer Screening Guideline: Frequently Asked Questions
After the release of the National Lung Screening Trial (NLST) results in late 2010, the American Cancer Society issued interim guidance for clinicians and adults at risk for lung cancer.
New Lung Cancer Screening Guidelines for Heavy Smokers
The American Cancer Society has published new guidelines that recommend doctors discuss lung cancer screening with people who meet certain criteria that put them at high risk for developing the disease.
Society-funded Research Sheds Light on Lung Cancer
More than 226,000 people will be diagnosed with lung cancer in 2012, according to estimates from the American Cancer Society. It is the leading cancer killer in the US, claiming both smokers and nonsmokers alike.
Frequently Asked Questions About Lung Cancer
Lung cancer is one of the more common cancers diagnosed in the US, and it’s often discovered in a later stage when it’s harder to treat. In 2012, an estimated 226,160 new cases will be diagnosed.
Genetic Link to Lung Cancer Risk in Asian Women
International researchers have linked 3 genetic regions to an increased risk for lung cancer among Asian women who have never smoked.
NFL Veteran Chris Draft Tackles Lung Cancer Awareness
Former NFL linebacker Chris Draft wants everybody to know the disturbing facts about lung cancer: that it kills more people than breast, prostate, colon, liver, and melanoma skin cancer combined.
World Health Organization Says Diesel Exhaust Causes Cancer
A group of experts from the World Health Organization (WHO) has classified diesel engine exhaust as a carcinogen – a substance that causes cancer.
Medical Groups OK Lung Cancer Screening for Heavy Smokers
The American College of Chest Physicians and the American Society of Clinical Oncology recommend that patients at greatest risk of developing lung cancer be screened with low-dose CT scans.
Study: Avastin May Not Help Older Lung Cancer Patients
Researchers at the Dana-Farber Cancer Institute have found that adding Avastin to chemotherapy treatment for non-small cell lung cancer likely does not help patients 65 years old or older live longer.
Some Smokers Diagnosed with Cancer Don’t Quit
For many smokers, a cancer diagnosis motivates them to quit. But researchers report that a “substantial minority” of lung and colon cancer patients are still smoking 5 months after their diagnosis.